Biogen Inc. (BVMF:BIIB34)
150.30
-4.70 (-3.03%)
Last updated: Jan 15, 2026, 3:46 PM GMT-3
Biogen Market Cap
Biogen has a market cap or net worth of 132.77 billion as of January 16, 2026. Its market cap has decreased by -2.67% in one year.
Market Cap
132.77B
Enterprise Value
146.89B
Revenue
53.65B
Ranking
n/a
PE Ratio
15.49
Stock Price
150.30
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 149.34M to 132.77B, an increase of 88,803.73%. That is a compound annual growth rate of 21.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 132.77B | -6.64% |
| Dec 31, 2025 | 142.21B | 3.18% |
| Dec 31, 2024 | 137.82B | -24.25% |
| Dec 29, 2023 | 181.94B | -13.70% |
| Dec 30, 2022 | 210.81B | 7.36% |
| Dec 31, 2021 | 196.36B | 0.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 89.02B |
| Raia Drogasil | 42.46B |
| Hypera | 14.96B |
| Fleury | 8.48B |
| Odontoprev | 5.76B |
| Diagnósticos da América | 5.30B |
| Empreendimentos Pague Menos | 4.32B |
| Oncoclínicas do Brasil Serviços Médicos | 3.03B |